Author Archives: eyeuser

NIGHT Study Enrollment (A Natural History Study of Choroideremia)

Our research team here at the University of Alberta, located in Edmonton, is one of a number of sites in North America and Europe currently working on a Natural History of Disease Study in choroideremia patients (called the NIGHT study … Continue reading

Posted in News | Comments Off on NIGHT Study Enrollment (A Natural History Study of Choroideremia)

Summer 2015

There has been a lot of activity in our research lab these past few months with the start of our clinical trial and with our summer students being around. We are excited to share some of the work with you! … Continue reading

Posted in News | Comments Off on Summer 2015

First Canadian ocular gene therapy trial begins!

We are excited to announce that our experimental gene therapy trial to treat choroideremia has began. Here is the official news release. This could not have been possible for our team without the involvement of our funding  partners and our patients, … Continue reading

Posted in News | Comments Off on First Canadian ocular gene therapy trial begins!

2015 Update #1 (edited)

Hello everyone! Here is a long overdue update! After plenty of hard work from both parties, the University of Alberta and NightstaRx have been able to finalize the research agreement necessary for this clinical trial to take place. The brand … Continue reading

Posted in News | Comments Off on 2015 Update #1 (edited)

A few steps closer…

We have now received our final No Objection Letter from Health Canada! Our group has been actively working with NightStaRx Ltd. on finalizing the research agreement between this new biopharmaceutical company and the University of Alberta. This legal document will … Continue reading

Posted in News | Comments Off on A few steps closer…

Trial recruitment expected to begin Fall 2014

As a recap of the year so far, our team at the University of Alberta has been hard at work preparing for our upcoming choroideremia gene therapy clinical trial.  The study details, including the criteria for participation can be found here. … Continue reading

Posted in News | Comments Off on Trial recruitment expected to begin Fall 2014

In Denver and in Edmonton.

Many members of our research team had the opportunity to attend the 2nd International Scientific Symposium for Choroideremia in Denver, Colorado in June 2014. This well-received 2-day symposium was organized by the Choroideremia Research Foundation for experts in many different … Continue reading

Posted in News | Comments Off on In Denver and in Edmonton.

Trial Approved by Health Canada

Happy New Year! We are looking forward to 2014 and all that it will bring. We finished off 2013 on a high note: receiving our No Objection Letter (NOL) from Health Canada! This of course, means we have regulatory approval … Continue reading

Posted in News | Comments Off on Trial Approved by Health Canada

Summer Update

Hi Everyone! We are all getting very excited about the upcoming trial this fall! In the last few months, we have had a pre-Clinical Trial Application (CTA) submission meeting with Health Canada and have since submitted our CTA. Now we … Continue reading

Posted in News | Comments Off on Summer Update

Alberta Ocular Gene Therapy Team Funded by Alberta Innovates-Health Solutions

28 March 2013. The Alberta Ocular Gene Therapy Team has been successful in securing $5 Million over 5 years from Alberta Innovates – Health Solutions. The Team, based at the University of Alberta, is led by Dr. Ian MacDonald, Chair … Continue reading

Posted in News | Comments Off on Alberta Ocular Gene Therapy Team Funded by Alberta Innovates-Health Solutions